Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
Phase 1
Completed
- Conditions
- Group A Streptococcal InfectionGram-Positive Bacterial InfectionsBacterial InfectionsStreptococcus Pyogenes PharyngitisStreptococcus PharyngitisStreptococcus Pyogenes InfectionStrep ThroatGroup A Streptococcus: B Hemolytic Pharyngitis
- First Posted Date
- 2017-12-04
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Andrew Steer
- Target Recruit Count
- 25
- Registration Number
- NCT03361163
- Locations
- 🇦🇺
Centre for Clinical Studies (Nucleus Network Limited), Melbourne, Victoria, Australia
News
No news found